Verastem, Inc. (VSTM)
Verastem, Inc. (VSTM) Company Bio
Verastem, Inc. focuses on discovering and developing drugs for the treatment of cancer. Its programs target the focal adhesion kinase (FAK) and the phosphoinositide 3-kinase (PI3K)/mTOR signaling pathways. The company was founded in 2010 and is based in Needham, Massachusetts.
VSTM Stock Chart More Charts
VSTM Price/Volume Stats
| Current price | $2.22 |
| Prev. close | $2.13 |
| Day low | $2.08 |
| Day high | $2.23 |
| 50-day MA | $2.97 |
| 200-day MA | $5.28 |
| 52-week high | $10.35 |
| 52-week low | $2.08 |
| Volume | 937,057 |
| Avg. volume | 2,654,115 |
| Dividend yield | N/A |
| Market Cap | 164.01M |
VSTM Returns
| 1-mo | -34.71% |
| 3-mo | -32.73% |
| 6-mo | -56.56% |
| 1-year | -45.99% |
| 3-year | 19.35% |
| 5-year | -71.68% |
| YTD | -33.93% |
| 2018 | 9.45% |
| 2017 | 174.11% |
| 2016 | -39.78% |
| 2015 | -79.65% |
| 2014 | -19.82% |
Loading social stream, please wait...